Professional articles

by EUROIMMUN

NEW AUTOMATION TECHNOLOGIES AT THE VANGUARD OF IFA DIAGNOSTICS

Featured in Clinical Laboratory International

EUROIMMUN has been creating innovative solutions for immunofluorescence diagnostics for over thirty years. Continuing this long tradition, the company ...

STANDARDISATION OF BIOMARKER MEASUREMENTS IN ALZHEIMER’S DISEASE DIAGNOSTICS

Featured in Omnia Health Magazine Jan/Feb 2022

Alzheimer’s disease is the most common cause of dementia in old age, accounting for 60 to 70 per cent of cases

MULTIPARAMETER AUTOANTIBODY TESTING IN AUTOIMMUNE NEUROLOGICAL DISEASES

Featured in Clinical Laboratory International

In recent years, there has been a growing understanding of the pathology of autoimmune neurological disorders, and the identification of the causal ...

FROM BIOCHIPS TO ARTIFICIAL INTELLIGENCE – DEFINING NEW HORIZONS IN IFA

Featured in Clinical Laboratory International

EUROIMMUN has been creating innovative solutions for immunofluorescence diagnostics for over thirty years. CLI talked to Dr. Panagiotis Grypiotis, Head ...

INVESTIGATION OF SARS-COV-2-SPECIFIC IMMUNE RESPONSES

Featured in Clinical Laboratory International

A thorough understanding of the immune response to SARS-CoV-2 is necessary for the evaluation of the efficacy of vaccines and vaccine candidates against ...

AUTOMATED IMMUNOFLUORESCENCE MICROSCOPY INCORPORATING AI

Featured in Omnia Health Magazine

Indirect immunofluorescence (IIF) is an important screening method for laboratory diagnostics due to its high sensitivity and specificity together with its broad ...

COMPREHENSIVE ANALYSIS OF SARS-COV-2 IMMUNE RESPONSES

Featured in Omnia Health Magazine

The development and duration of immunity to SARS-CoV-2 following infection or vaccination is not fully understood, but increased knowledge is crucial for the ...

MONITORING THERAPEUTIC DRUG DOSAGE IN RHEUMATIC DISEASES, CHRONIC INFLAMMATORY BOWEL DISEASES AND PSORIASIS

Featured in Clinical Laboratory International

Tumour necrosis factor (TNF) inhibitors are increasingly used to treat chronic inflammatory bowel diseases, rheumatic diseases and psoriasis. Continuous ...

Back to top